Baseline characteristics
| Parameter | miLOOP+phaco n=53 | Control phaco n=48 |
| Age (years) | 70.2±10.3 | 67.7±9.9 |
| Range | 45‒87 | 38‒87 |
| Gender, female, n (%) | 29 (55) | 21 (44) |
| Cataract grade | 3.55±0.50 | 3.58±0.50 |
| Ocular comorbidities, n (%) | ||
| Glaucoma | 16 (30) | 8 (17) |
| Significant myopia | 2 (4) | 1 (2) |
| Other* | 4 (8) | 4 (8) |
| Axial length (mm) | 23.73±0.96 | 23.56±0.95 |
| Range | 21.52‒27.88 | 22.04‒25.81 |
| Endothelial cell density (cells/mm2) | 2592±220 | 2650±189 |
| Range | 2066‒3000 | 2151‒2950 |
| Central corneal thickness (µm) | 542±45 | 553±39 |
| Range | 451‒648 | 464‒651 |
| Baseline BCVA, decimal | 0.056±0.09 | 0.050±0.1 |
| (Snellen equivalent) | (20/360) | (20/400) |
*Other ocular comorbidities include ocular hypertension (n=4), and one each of diabetic retinopathy, traumatic glaucoma, pterygium nasal and ptosis. Values are presented as mean±SD unless otherwise indicated. Percentage values are rounded to the nearest integer.
BCVA, best corrected visual acuity; miLOOP, microinterventional loop prefragmentation.